Related references
Note: Only part of the references are listed.The Changing Landscape of Hepatocellular Carcinoma Etiology, Genetics, and Therapy
Erik S. Knudsen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Myeloid-derived suppressor cell heterogeneity in human cancers
Samantha Solito et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Immune Modulation in Cancer with Antibodies
David B. Page et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review
Klara Miriam Elfstrom et al.
CURRENT OPINION IN ONCOLOGY (2014)
DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice
Armina Alagheband Bahrami et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer
Tim Dalessandri et al.
FRONTIERS IN IMMUNOLOGY (2014)
Regulation of interlocking gene regulatory network subcircuits by a small molecule inhibitor of retinoblastoma protein (RB) phosphorylation: Cancer cell expression of HLA-DR
Smitha Pillai et al.
GENE (2013)
Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes
Fang Zhou et al.
JOURNAL OF GENERAL VIROLOGY (2013)
The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression
Naveed Shahzad et al.
JOURNAL OF VIROLOGY (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation
Hao Yuan Kueh et al.
SCIENCE (2013)
Different Regions of the HPV-E7 and Ad-E1A Viral Oncoproteins Bind Competitively but through Distinct Mechanisms to the CH1 Transactivation Domain of p300
Daniela Fera et al.
BIOCHEMISTRY (2012)
Rb/E2F1 Regulates the Innate Immune Receptor Toll-Like Receptor 3 in Epithelial Cells
Manabu Taura et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
New Paradigms in Type 2 Immunity
Bali Pulendran et al.
SCIENCE (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
A Shared Role for RBF1 and dCAP-D3 in the Regulation of Transcription with Consequences for Innate Immunity
Michelle S. Longworth et al.
PLoS Genetics (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Targeting the RB-pathway in Cancer Therapy
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2010)
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells
Minu K. Srivastava et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Retinoblastoma protein expression predicts response to bacillus Calmette-Guerin immunotherapy in patients with T1G3 bladder cancer
Luigi Cormio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit
Lijun Xu et al.
MOLECULAR IMMUNOLOGY (2009)
Activation of NF-kB Pathway by Virus Infection Requires Rb Expression
Maria A. Garcia et al.
PLOS ONE (2009)
Direct Binding of pRb/E2F-2 to GATA-1 Regulates Maturation and Terminal Cell Division during Erythropoiesis
Zahra Kadri et al.
PLOS BIOLOGY (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family
Patrick Viatour et al.
CELL STEM CELL (2008)
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes
James A. Thompson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Tailoring to RB: tumour suppressor status and therapeutic response
Erik S. Knudsen et al.
NATURE REVIEWS CANCER (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function
M. P. Markey et al.
ONCOGENE (2007)
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment
Carl R. Walkley et al.
CELL (2007)
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4+ T lymphocytes that cross-react with primary and metastatic weal melanoma cells
Jacobus J. Bosch et al.
CANCER RESEARCH (2007)
Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
Kesavan Esuvaranathan et al.
CANCER (2007)
Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line
AR Osborne et al.
MOLECULAR IMMUNOLOGY (2006)
Retinoblastoma protein acts as Pax 8 transcriptional coactivator
S Miccadei et al.
ONCOGENE (2005)
Activation of tumor-specific CD4+ T lymphocytes by major histocompatibility complex class II tumor cell vaccines:: A novel cell-based immunotherapy
SK Dissanayake et al.
CANCER RESEARCH (2004)
The critical role of type-1 innate and acquired immunity in tumor immunotherapy
H Ikeda et al.
CANCER SCIENCE (2004)
Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells - An Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter
AR Osborne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Brain tumors and polyomaviruses
S Croul et al.
JOURNAL OF NEUROVIROLOGY (2003)
PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation
N Rekhtman et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Role of the E1A Rb-binding domain in repression of the NF-κB-dependent defense against tumor necrosis factor-α
JL Cook et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation
A Osborne et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation
DM Thomas et al.
MOLECULAR CELL (2001)
pRB induces Sp1 activity by relieving inhibition mediated by MDM2
T Johnson-Pais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Retinoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription
A Charles et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Interferon α/β-mediated inhibition and promotion of interferon γ:: STATI resolves a paradox
KB Nguyen et al.
NATURE IMMUNOLOGY (2000)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
